TrialPaediatric drugs2016

Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial.

Robert L Findling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.